|
36 Companies |
|
49 Products |
|
49 Products |
|
44 Mechanisms of Action |
|
1 Trial |
|
1039 News |
|
| 12345678910111213...2021» |
- | Trial completion: RCT ATE/ATT: ATT Compared With ATE in OSAS Children (clinicaltrials.gov) - Mar 10, 2023
P=N/A, N=79, Completed, Sponsor: Karolinska University Hospital
Unknown status --> Completed
- | Trial completion date, Trial primary completion date: In-Hospital Portable Sleep Monitoring for the Evaluation of Obstructive Sleep Apnea (OSA) (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=140, Active, not recruiting, Sponsor: John H. Stroger Hospital
Unknown status --> Completed Trial completion date: Mar 2016 --> Dec 2024 | Trial primary completion date: Feb 2015 --> Jun 2022
- ||||| sodium oxybate / Generic mfg.
Trial completion, Trial completion date: A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy (clinicaltrials.gov) - Apr 30, 2019
P3, N=106, Completed, Sponsor: Jazz Pharmaceuticals
Trial completion date: Mar 2016 --> Dec 2024 | Trial primary completion date: Feb 2015 --> Jun 2022 Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Jan 2019
- | NN1213 / Novo Nordisk
Enrollment change: Using Continuous Positive Airway Pressure to Reduce the Incidence of Acute Kidney Injury in Hospitalized Patients With Chronic Kidney Disease (clinicaltrials.gov) - Apr 29, 2019
P=N/A, N=0, Withdrawn, Sponsor: University of South Florida
Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Jan 2019 N=125 --> 0
- ||| Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK
Trial completion: Specified Drug Use-Results Survey of Regnite (clinicaltrials.gov) - Apr 29, 2019
P=N/A, N=1597, Completed, Sponsor: Astellas Pharma Inc
N=125 --> 0 Active, not recruiting --> Completed
- || Enrollment change: Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=44, Completed, Sponsor: Philips Respironics
Active, not recruiting --> Completed N=20 --> 44
- | Trial completion: Morphee: Down Syndrome and Continuous Positive Pressure Therapy (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=31, Completed, Sponsor: Institut Jerome Lejeune
N=20 --> 44 Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: Exploring the Role of Adipocyte Fatty Acid Binding Protein in the Association of Obstructive Sleep Apnea and Metabolic Dysfunction (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=90, Completed, Sponsor: The University of Hong Kong
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018
- ||| NN1213 / Novo Nordisk
Trial completion, Enrollment change: Investigative Headgear With CPAP Mask (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=23, Completed, Sponsor: Fisher and Paykel Healthcare
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018 Enrolling by invitation --> Completed | N=300 --> 23
- | Trial completion: MATRICS: Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=121, Completed, Sponsor: Northwestern University
Enrolling by invitation --> Completed | N=300 --> 23 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date, Surgery: Randomized Control Trials of Surgery for Pediatric OSA (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=143, Completed, Sponsor: Karolinska University Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
- | Phase classification, Enrollment change: Mild Cognitive Impairment and Obstructive Sleep Apnea (clinicaltrials.gov) - Jan 29, 2019
P=N/A, N=54, Completed, Sponsor: George Mason University
Active, not recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 Phase classification: P3 --> P=N/A | N=86 --> 54
- | Trial completion, Trial completion date, Trial primary completion date: SAMSPAP: Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial (clinicaltrials.gov) - Jan 11, 2019
P=N/A, N=49, Completed, Sponsor: McGill University
Phase classification: P3 --> P=N/A | N=86 --> 54 Recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2018 | Trial primary completion date: Sep 2018 --> Nov 2018
- | NN1213 / Novo Nordisk
Trial completion date, Trial termination: Intermittent Hypoxia 2: Cardiovascular and Metabolism (clinicaltrials.gov) - Dec 31, 2018
P4, N=12, Terminated, Sponsor: University Hospital, Grenoble
Recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2018 | Trial primary completion date: Sep 2018 --> Nov 2018 Trial completion date: Dec 2017 --> Mar 2017 | Active, not recruiting --> Terminated; budget constraints
- | Trial completion, Enrollment change: Neurophysiologic Correlates of Hypersomnia (clinicaltrials.gov) - Dec 24, 2018
P=N/A, N=76, Completed, Sponsor: University of Wisconsin, Madison
Trial completion date: Dec 2017 --> Mar 2017 | Active, not recruiting --> Terminated; budget constraints Recruiting --> Completed | N=240 --> 76
- || Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK
Enrollment closed: Specified Drug Use-Results Survey of Regnite (clinicaltrials.gov) - Dec 17, 2018
P=N/A, N=1597, Active, not recruiting, Sponsor: Astellas Pharma Inc
Recruiting --> Completed | N=240 --> 76 Recruiting --> Active, not recruiting
- NN1213 / Novo Nordisk
Enrollment change: Obesity Hypoventilation Syndrome Prevalence Study (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=44, Terminated, Sponsor: Philips Respironics
Recruiting --> Active, not recruiting N=200 --> 44
- ||| NN1213 / Novo Nordisk
Trial completion, Trial completion date: NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=32, Completed, Sponsor: Medical University of South Carolina
N=200 --> 44 Active, not recruiting --> Completed | Trial completion date: Apr 2017 --> Jul 2017
- | lansoprazole / Generic mfg.
Enrollment change, Trial withdrawal: Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea (clinicaltrials.gov) - Dec 10, 2018
P=N/A, N=0, Withdrawn, Sponsor: MetroHealth Medical Center
Active, not recruiting --> Completed | Trial completion date: Apr 2017 --> Jul 2017 N=50 --> 0 | Terminated --> Withdrawn
- | montelukast / Generic mfg.
Trial completion: Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA) (clinicaltrials.gov) - Dec 3, 2018
P3, N=34, Completed, Sponsor: Romaker & Associates
N=50 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Impact of CPAP Therapy in Obstructive Sleep Apnea on Parameters of Nocturnal Pulse Wave Analysis (clinicaltrials.gov) - Oct 30, 2018
P=N/A, N=314, Completed, Sponsor: Wissenschaftliches Institut Bethanien e.V
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017 | Trial primary completion date: Dec 2017 --> May 2017
- | Trial completion, Phase classification, Trial completion date, Trial primary completion date: ISAACC: Continuous Positive Airway Pressure (CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA) (clinicaltrials.gov) - Oct 17, 2018
P=N/A, N=1864, Completed, Sponsor: Sociedad Espa
Recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017 | Trial primary completion date: Dec 2017 --> May 2017 Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Sep 2017 --> Sep 2018
- | aspirin / Generic mfg.
Enrollment change, Trial termination: Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients (clinicaltrials.gov) - Oct 12, 2018
P=N/A, N=53, Terminated, Sponsor: University Hospital, Grenoble
Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Sep 2017 --> Sep 2018 N=286 --> 53 | Recruiting --> Terminated; Recommendations changing
- | Trial completion, Enrollment change: TNI: Trans Nasal Insufflation for the Treatment of Snoring (clinicaltrials.gov) - Sep 18, 2018
P=N/A, N=11, Completed, Sponsor: Johns Hopkins University
N=286 --> 53 | Recruiting --> Terminated; Recommendations changing Active, not recruiting --> Completed | N=100 --> 11
- | Trial completion, Trial completion date, Trial primary completion date: Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS (clinicaltrials.gov) - Sep 11, 2018
P=N/A, N=60, Completed, Sponsor: Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Active, not recruiting --> Completed | N=100 --> 11 Recruiting --> Completed | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018
- | NN1213 / Novo Nordisk
Trial completion, Compliance: Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS (clinicaltrials.gov) - Aug 31, 2018
P=N/A, N=211, Completed, Sponsor: ONIRIS
Recruiting --> Completed | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Effect of Renal Transplantation on Obstructive Sleep Apnea in End Stage Renal Disease Patients (SASinTx) (clinicaltrials.gov) - Aug 15, 2018
P=N/A, N=40, Completed, Sponsor: Centre Hospitalier Universitaire Vaudois
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Mar 2018 --> Dec 2017
- | Trial primary completion date: Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children (clinicaltrials.gov) - Aug 1, 2018
P=N/A, N=120, Completed, Sponsor: University of Michigan
Recruiting --> Completed | Trial completion date: Mar 2018 --> Dec 2017 Trial primary completion date: Jul 2017 --> Oct 2017
- | Trial completion, Phase classification: The Effects of Continuous Positive Airway Pressure on Overlap Syndrome (clinicaltrials.gov) - Jul 18, 2018
P=N/A, N=90, Completed, Sponsor: Chang Gung Memorial Hospital
Trial primary completion date: Jul 2017 --> Oct 2017 Recruiting --> Completed | Phase classification: P4 --> PN/A
- ||| NN1213 / Novo Nordisk
Trial completion: Respicardia, Inc. Pivotal Trial of the remed? System (clinicaltrials.gov) - Jun 29, 2018
P=N/A, N=151, Completed, Sponsor: Respicardia, Inc.
Recruiting --> Completed | Phase classification: P4 --> PN/A Active, not recruiting --> Completed
- | Enrollment change, Trial termination: SAS-FOOT: Impact of Sleep Apnea on Diabetic Foot Wound. (clinicaltrials.gov) - Jun 28, 2018
P=N/A, N=35, Terminated, Sponsor: AGIR
Active, not recruiting --> Completed N=60 --> 35 | Recruiting --> Terminated; Difficulty including subjects corresponding to the criteria.
- | NN1213 / Novo Nordisk
Enrollment closed, Surgery: Randomized Control Trials of Surgery for Pediatric OSA (clinicaltrials.gov) - Jun 13, 2018
P=N/A, N=143, Active, not recruiting, Sponsor: Karolinska University Hospital
N=60 --> 35 | Recruiting --> Terminated; Difficulty including subjects corresponding to the criteria. Recruiting --> Active, not recruiting
- | NN1213 / Novo Nordisk
Trial termination: The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease (clinicaltrials.gov) - Jun 8, 2018
P=N/A, N=1, Terminated, Sponsor: Yale University
Recruiting --> Active, not recruiting Completed --> Terminated; We were not able to recruit participants.
- | Enrollment closed: MATRICS: Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea (clinicaltrials.gov) - Apr 30, 2018
P=N/A, N=140, Active, not recruiting, Sponsor: Northwestern University
Completed --> Terminated; We were not able to recruit participants. Recruiting --> Active, not recruiting
- Phase classification, Enrollment change: CIA-6: Effects of Humidity (During CPAP Treatment) on Mucociliary Clearance in Patients With Obstructive Sleep Apnea (clinicaltrials.gov) - Apr 27, 2018
P=N/A, N=4, Terminated, Sponsor: Fisher and Paykel Healthcare
Recruiting --> Active, not recruiting Phase classification: P1/2 --> P=N/A | N=20 --> 4
- | Trial completion, Trial completion date, Bariatric surgery: The Effect of Lifestyle Intervention Versus Gastric Bypass on Various Comorbidities in Morbidly Obese Subjects (clinicaltrials.gov) - Apr 19, 2018
P=N/A, N=180, Completed, Sponsor: The Hospital of Vestfold
Phase classification: P1/2 --> P=N/A | N=20 --> 4 Active, not recruiting --> Completed | Trial completion date: Dec 2025 --> Dec 2017
- | Biomarker, Trial completion: Nasal and Oronasal Mask in Severe OSA Patients With Nasal Free Airflow of Obstruction (clinicaltrials.gov) - Apr 19, 2018
P=N/A, N=25, Completed, Sponsor: University of Sao Paulo
Active, not recruiting --> Completed | Trial completion date: Dec 2025 --> Dec 2017 Recruiting --> Completed
- || Neupro (rotigotine transdermal) / Otsuka, UCB
Phase classification: Effect on RLS Symptom Severity After Switching to Neupro (clinicaltrials.gov) - Apr 4, 2018
P, N=102, Completed, Sponsor: UCB Pharma
Recruiting --> Completed Phase classification: P=N/A --> P
- || Trial primary completion date, Compliance: Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS (clinicaltrials.gov) - Apr 4, 2018
P=N/A, N=204, Active, not recruiting, Sponsor: ONIRIS
Phase classification: P=N/A --> P Trial primary completion date: Dec 2017 --> Apr 2018
- || Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK
Phase classification: Specified Drug Use-Results Survey of Regnite (clinicaltrials.gov) - Mar 31, 2018
P, N=1500, Recruiting, Sponsor: Astellas Pharma Inc
Trial primary completion date: Dec 2017 --> Apr 2018 Phase classification: P=N/A --> P
- | Phase classification, Trial withdrawal: Initiation of Auto-adjusting CPAP for Newly Diagnosed OSA in Hospitalized Patients (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=0, Withdrawn, Sponsor: MetroHealth Medical Center
Phase classification: P=N/A --> P Phase classification: P2/3 --> P=N/A | Terminated --> Withdrawn
- || Trial completion date, Trial primary completion date: Investigative Headgear With CPAP Mask (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=300, Enrolling by invitation, Sponsor: Fisher and Paykel Healthcare
Phase classification: P2/3 --> P=N/A | Terminated --> Withdrawn Trial completion date: Mar 2017 --> Dec 2018 | Trial primary completion date: Mar 2017 --> Dec 2018
- | Trial completion date, Trial primary completion date: SAMSPAP: Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial (clinicaltrials.gov) - Mar 21, 2018
P=N/A, N=65, Recruiting, Sponsor: McGill University
Trial completion date: Mar 2017 --> Dec 2018 | Trial primary completion date: Mar 2017 --> Dec 2018 Trial completion date: Jun 2018 --> Mar 2019 | Trial primary completion date: Dec 2017 --> Sep 2018
- | Enrollment change, Trial termination: Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea (clinicaltrials.gov) - Mar 20, 2018
P=N/A, N=48, Terminated, Sponsor: Queen's University
Trial completion date: Jun 2018 --> Mar 2019 | Trial primary completion date: Dec 2017 --> Sep 2018 N=80 --> 48 | Recruiting --> Terminated; Most OSA patients were not obese and/or admitted over night so the study was not feasible.
- Enrollment change: Pilot Study of Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=34, Terminated, Sponsor: Somnics, Inc.
N=80 --> 48 | Recruiting --> Terminated; Most OSA patients were not obese and/or admitted over night so the study was not feasible. N=25 --> 34
- | Trial completion, Enrollment change: IMPACT Obesity: Does Treating Obstructive Sleep Apnea in Obese Canadian Youth Improve Blood Sugar Control? (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=27, Completed, Sponsor: Katz, Sherri Lynne, M.D.
N=25 --> 34 Recruiting --> Completed | N=54 --> 27
- | Trial completion, Enrollment change: Co-existent Obstructive Sleep Apnea (OSA) and Obesity: Finding Non-exercise Activity Thermogenesis (NEAT) Targets for Intervention (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=9, Completed, Sponsor: Katz, Sherri Lynne, M.D.
Recruiting --> Completed | N=54 --> 27 Recruiting --> Completed | N=40 --> 9
- Phase classification: Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS) (clinicaltrials.gov) - Feb 20, 2018
P2a, N=45, Completed, Sponsor: Luitpold Pharmaceuticals
Recruiting --> Completed | N=40 --> 9 Phase classification: P2 --> P2a
- | Trial completion, Enrollment change, Trial primary completion date: Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea (clinicaltrials.gov) - Feb 6, 2018
P=N/A, N=130, Completed, Sponsor: Eastern Virginia Medical School
Phase classification: P2 --> P2a Recruiting --> Completed | N=25 --> 130 | Trial primary completion date: Feb 2015 --> Jun 2016
- | rosuvastatin / Generic mfg.
Enrollment change: The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome (clinicaltrials.gov) - Feb 1, 2018
P4, N=46, Completed, Sponsor: Chang Gung Memorial Hospital
Recruiting --> Completed | N=25 --> 130 | Trial primary completion date: Feb 2015 --> Jun 2016 N=120 --> 46